People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| T2 Biosystems, Inc. | — | Other Technology | Series D+ | $477.6M | $1.3B | 2010 |
| Seventh Sense Biosystems, Inc. | — | Biotechnology | Series B | $62.9M | $732.6M | 2010 |
DOUG LEVINSON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DOUG LEVINSON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 2 | 36 |
| Alan Crane | 2 | 9 |
| Harry Wilcox | 2 | 6 |
| Michael Greeley | 1 | 15 |
| Doug Cole | 1 | 6 |
| Adrian M. Jones | 1 | 5 |
| John McDonough | 1 | 5 |
| NEIL EXTER | 1 | 5 |
| PETER HUTT | 1 | 4 |
| Timothy Richards | 1 | 4 |
| Michael Cima | 1 | 4 |
| HOWARD WEISMAN | 1 | 3 |
| R. ROX ANDERSON | 1 | 3 |
| Milan Kofol | 1 | 2 |
| John W. Cumming | 1 | 2 |
| Stacy Feld | 1 | 2 |
| HOWARD BERNSTEIN | 1 | 2 |
| Thomas Lowery | 1 | 2 |
| AMY SIEGEL | 1 | 2 |
| Stuart Blitz | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.